Dr. Alane O’Connor specializes in addiction medicine. For the past 15 years, she led MaineGeneral Medical Center’s efforts to expand access to substance use treatment including rapid access buprenorphine in the ED, implementing the high-acuity step down program, Outpatient Plus, expanding access in primary care and developing an inpatient substance use disorder consult service. During that time, Dr. O’Connor was faculty at Maine Dartmouth Family Medicine Residency, educating more than 100 resident physicians, and led several grant-funded projects in substance use disorder prevention and harm reduction. She has a particular interest in caring for pregnant women with substance use disorders and has published numerous peer-reviewed articles both here and abroad on infant outcomes following buprenorphine exposure during pregnancy. In May, Dr. O’Connor became the medical advisor of the Maine Maternal Opioid Misuse (MaineMOM) Initiative, a 5-year, $5 million federal grant that will expand access to substance use treatment services for pregnant women in all of Maine’s 16 counties. As the first director of perinatal addiction treatment at Maine Medical Center, she will continue training resident physicians while implementing a program that serves pregnant women in the Portland area. Dr. O’Connor is also delighted to continue her rural addiction medicine roots by joining Kennebec Behavioral Health’s Opioid Health Home in Skowhegan part-time. Finally, Dr. O’Connor co-chairs Maine’s Opioid Response Clinical Advisory Committee, which advises the Governor’s opioid response director on clinical and public policy issues.